ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0005

Differential Glomerular Pathomics and Spatial Transcriptomics in Short and Long-Looped Nephrons: Insights from Human and Mouse Models

Session Information

Category: Artificial Intelligence, Digital Health, and Data Science

  • 300 Artificial Intelligence, Digital Health, and Data Science

Authors

  • Yin, Mengmeng, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China
  • Yang, Yuechen, Vanderbilt University, Nashville, Tennessee, United States
  • Wang, Yu, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Deng, Ruining, Weill Cornell Medicine, New York, New York, United States
  • Liu, Jing, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Zhao, Shilin, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Fogo, Agnes B., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Huo, Yuankai, Vanderbilt University, Nashville, Tennessee, United States
  • Yang, Haichun, Vanderbilt University Medical Center, Nashville, Tennessee, United States
Background

Nephrons in the kidney include short-looped (SLN) and long-looped nephrons (LLN). SLN and LLN glomeruli differ in cortical location, size, mesangial morphology, and disease susceptibility. This study analyzes these differences using pathomics and spatial transcriptomics from human samples and diseased mouse kidneys.

Methods

We examined 105 non-tumor nephrectomy samples. These included patients without comorbid conductions as well as individuals with hypertension, diabetes, and/or aging conditions. Mouse models included normal mice, angiotensin II + high salt-treated mice (model of hypertension), db/db eNOS-/- mice (model of T2 diabetes), and aging mice. An AI-driven pipeline was used for the segmentation and pathomics quantification and comparison of SLN and LLN glomeruli. Spatial transcriptomics was performed on diabetic human kidney samples and db/db eNOS-/- mice.

Results

In all human samples, SLN glomeruli showed greater glomerulosclerosis and mesangial intensity (a pathomics feature related to pixel density) than LLN. Both hypertension and aging showed more probability of glomerulosclerosis in SLN and LLN glomeruli vs those without conditions, whereas diabetes was linked to glomerular hypertrophy in both SLN and LLN. In mice, aging increased mesangial expansion and intensity in SLN, but not in LLN glomeruli. Hypertension and diabetes induced similar pathomic changes in SLN and LLN glomeruli compared to control mice. Spatial transcriptomics identified 742 differentially expressed genes (DEGs) in diabetic SLN glomeruli vs normal samples, whereas only 24 DEGs were found in LLN glomeruli. DEGs in SLN glomeruli were associated with endothelial injury and matrix regulation pathways. In db/db eNOS-/- mice, SLN showed more DEGs than LLN at week 10, an early stage of diabetic nephropathy, but similar DEGs in both types by week 18, a later stage.

Conclusion

Our AI-driven pathomics analysis revealed distinct morphological responses in SLN and LLN glomeruli across various diseases. Spatial transcriptomics highlighted molecular changes related to endothelial injury and matrix regulation preceding morphological alterations and further differentiated SLN and LLN responses.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)